Summary:
This study will evaluate weight gain of ALKS 3831 compared to olanzapine in adult subjects with schizophrenia.
Qualified Participants Must:
Be between 18 and 55 years of age (Adult)
Be diagnosed with Schizoprenia
Qualified Participants May Receive:
Study-related medical care and investigational medication at no cost and may be compensated for time and travel.